Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Pediatr Radiol ; 51(1): 94-102, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-32889585

RESUMEN

BACKGROUND: Pediatric bone marrow assessment by MRI is challenging and primarily experiential and qualitative, with a paucity of clinically useful quantitative imaging techniques. OBJECTIVE: MRI fat fraction (MRI-FF) is a technique used to quantify the degree of fat in other organ systems. The purpose of this study was to assess whether MRI-FF accurately measures bone marrow composition. MATERIALS AND METHODS: This two-part study included a validation phase, followed by an application phase. For the validation phase, the MRI-FF of piglet bones (6 long bones, 8 axial bones) was performed at 1.5 tesla (T) and 3.0 T, and correlated to the histological fat fraction (H-FF). We used Bland-Altman plots to compare MRI-FF at 1.5 tesla T and 3.0 T. For the application phase, five children with malignant marrow disease were recruited along with seven age- and gender-matched control subjects. The MRI-FF in the children was correlated to the H-FF. Boxplots were used to compare the MRI-FF of patients and control subjects. RESULTS: For the validation animal study, the MRI-FF of piglet bones at both 1.5 T and 3.0 T demonstrated moderate positive correlation to H-FF (r=0.41 and 0.42, respectively). MRI-FF at 1.5 T and 3.0 T were in good agreement, on average 7.7% apart. For the application phase, we included 5 children (4 with leukemia, 1 rhabdomyosarcoma) with median age 7 years, range (3-10 years). All children had MRI-FF and H-FF below 10%. The MRI-FF in patients (3.8±1.2) was significantly lower than that of control subjects (46.1±12.3%) (P<0.01). CONCLUSION: MRI-FF is a valid technique to assess bone marrow fat fraction at both 1.5 T and 3.0 T. The MRI-FF in children with malignant marrow processes is significantly lower than in control subjects with normal marrow.


Asunto(s)
Médula Ósea , Neoplasias , Tejido Adiposo , Animales , Médula Ósea/diagnóstico por imagen , Niño , Preescolar , Humanos , Imagen por Resonancia Magnética , Porcinos
3.
Bioorg Med Chem ; 16(6): 3067-75, 2008 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-18226531

RESUMEN

Kv1.1 channels are expressed in many regions of the brain and spinal cord [Monaghan, M. M.; Trimmer, J. S.; Rhodes, K. J. J. Neurosci.2001, 21, 5973; Rasband, M. N.; Trimmer, J. S. J. Comp. Neurol.2001, 429, 166; Trimmer, J. S.; Rhodes, K. J. Ann. Rev. Physiol.2004, 66, 477]. When expressed alone, they produce a delayed rectifier slowly inactivating type current that contributes to hyperpolarizing the neuron following depolarization. In the hippocampus Kv1.1 is co-expressed with Kvbeta1 (and other beta subunits), which converts Kv1.1 into a transient, fast inactivating current, reducing its ability to hyperpolarize the cell and thus increasing neuronal excitability. To reduce neuronal excitability, screening for compounds that prevent inactivation of Kv1.1 channels by Kvbeta1 was performed using a yeast two-hybrid screen. A variety of compounds were discovered in this assay and subsequently determined to disrupt inactivation of the ionic currents, and hence were termed 'disinactivators'. Several of these disinactivators also inhibited pentylenetetrazole-induced seizures (PTZ) in mice. Compounds were found to act by several mechanisms to prevent Kvbeta1 inactivation of Kv1.1 channels, including enhancement of Ca(2+) release/influx and by direct mechanisms. Two structural classes were identified that act on a Kvbeta1N70-Kv1.1 chimera where the N-terminal 70 amino acids of Kvbeta1 were attached to the N-terminus of Kv1.1. It is likely that these disinactivators act directly on the Kvbeta1 N-terminus or its receptor site on Kv1.1, thus preventing it from blocking Kv1.1 channels. Compounds acting by this mechanism may be useful for reducing neuronal hyperexcitability in diseases such as epilepsy and neuropathic pain.


Asunto(s)
Canal de Potasio Kv.1.1/efectos de los fármacos , Compuestos Orgánicos/farmacología , Bibliotecas de Moléculas Pequeñas , Animales , Calcio/metabolismo , Potenciales de la Membrana/efectos de los fármacos , Ratones , Convulsiones/prevención & control , Relación Estructura-Actividad , Técnicas del Sistema de Dos Híbridos
4.
Oncotarget ; 8(26): 42548-42559, 2017 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-28476021

RESUMEN

Obesity is a prominent risk factor for endometrial cancer (EC) and can impede on surgical and hormonal treatments. Markers of EC, estrogen receptor (ER), progesterone receptor (PR), phospho(Ser473)-AKT (pAKT) and 14-3-3 sigma (14-3-3σ) were measured in EC tissues in both the tumor and stroma and grouped by body mass index (BMI). Immunohistochemical scoring of 82 cases of Type 1 and Type II EC tissues revealed a significantly increased tumor expression of ER, PR and 14-3-3σ in women with Type I (BMI < 40) as compared to Type II (BMI < 30) EC. With higher BMI, only PR and 14-3-3σ in the tumor epithelium was significantly higher in Type I than Type II. In particular, Type I EC exhibited significantly increased levels of only PR from patients with BMI > 40 compared to BMI < 40. Type II EC showed increased expression of ER in the stroma only between high and low BMI. Analysis of the TCGA RNA-Seq mRNA expression of ER, PR, PIK3CA, PTEN and SFN (gene for 14-3-3σ) confirmed increased PR expression in EC of obese women. In conclusion, ER, PR and 14-3-3σ are differentially regulated in Type I compared to Type II EC while PR is dysregulated in obese women with Type I EC. These findings have potential implications for efficacy of progestin treatment in obese women.


Asunto(s)
Proteínas 14-3-3/genética , Biomarcadores de Tumor/genética , Índice de Masa Corporal , Neoplasias Endometriales/etiología , Neoplasias Endometriales/metabolismo , Exorribonucleasas/genética , Expresión Génica , Receptores de Estrógenos/genética , Receptores de Progesterona/genética , Células del Estroma/metabolismo , Proteínas 14-3-3/metabolismo , Biomarcadores de Tumor/metabolismo , Neoplasias Endometriales/patología , Exorribonucleasas/metabolismo , Femenino , Genómica/métodos , Humanos , Inmunohistoquímica , Obesidad/complicaciones , Obesidad/metabolismo , Receptores de Estrógenos/metabolismo , Receptores de Progesterona/metabolismo , Análisis de Matrices Tisulares
5.
Diagn Cytopathol ; 43(5): 432-7, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25431027

RESUMEN

Membranous basal cell adenoma (MBCA) is a rare benign salivary gland neoplasm. It is difficult to diagnose MBCA based on fine-needle aspiration (FNA) cytology due to rare reporting of its FNA cytology and overlapping of its FNA cytologic features with some benign and malignant entities. We present a case of MBCA in a 67-year-old female that was originally misinterpreted as adenoid cystic carcinoma (ACC) on FNA cytology. The FNA smears showed numerous uniform small basaloid epithelial cells with round or oval nuclei and inconspicuous nucleoli, and scant cytoplasm. The basaloid cells surround acellular, dense, homogenous material or are surrounded by acellular or paucicellular dense homogeneous material possibly containing bland spindle cells. The basaloid cells are present in variably sized three-dimensional clusters, acini, or sheets with variable cohesion. The dense homogenous material surrounded by basaloid cells may be interconnected. High power magnification reveals the homogeneous material to have a fibrillar texture. The edges of dense homogenous materials were well-demarcated. We describe the diagnostic pitfalls of FNA for MBCA, particularly versus ACC, basal cell adenoma, cellular pleomorphic adenoma, myoepithelioma, basal cell adenocarcinoma, and basaloid squamous cell carcinoma in hope of improving clinical management and patient treatment.


Asunto(s)
Adenocarcinoma/diagnóstico , Adenoma Pleomórfico/diagnóstico , Adenoma/diagnóstico , Carcinoma Adenoide Quístico/diagnóstico , Carcinoma de Células Escamosas/diagnóstico , Mioepitelioma/diagnóstico , Neoplasias de la Parótida/diagnóstico , Adenocarcinoma/patología , Adenoma/patología , Adenoma Pleomórfico/patología , Anciano , Biopsia con Aguja Fina , Carcinoma Adenoide Quístico/patología , Carcinoma de Células Escamosas/patología , Diagnóstico Diferencial , Células Epiteliales/patología , Femenino , Humanos , Mioepitelioma/patología , Glándula Parótida/patología , Neoplasias de la Parótida/patología
6.
Int J Surg Pathol ; 23(5): 409-13, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26041740

RESUMEN

Malignant melanoma has a variety of morphologic patterns and can metastasize and mimic any type of neoplastic process creating significant diagnostic difficulty. When metastasis to the gastrointestinal system is identified, it is most commonly associated with widely metastatic disease. We report a rare case of isolated gallbladder intramucosal metastatic melanoma with features mimicking lymphoepithelial carcinoma in an adult patient who presented with cholecystitis. Additionally, we report the imaging and morphologic features and discuss the importance of these findings along with a clear clinical history and immunohistochemical profile to make a definitive diagnosis.


Asunto(s)
Neoplasias de la Vesícula Biliar/secundario , Melanoma/secundario , Neoplasias Cutáneas/patología , Colecistografía , Diagnóstico Diferencial , Vesícula Biliar/diagnóstico por imagen , Vesícula Biliar/patología , Neoplasias de la Vesícula Biliar/diagnóstico , Humanos , Masculino , Melanoma/diagnóstico , Persona de Mediana Edad , Membrana Mucosa/patología , Tomografía Computarizada por Rayos X , Ultrasonografía
7.
Proc Natl Acad Sci U S A ; 104(15): 6406-11, 2007 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-17379666

RESUMEN

Circadian rhythms and the genes that make up the molecular clock have long been implicated in bipolar disorder. Genetic evidence in bipolar patients suggests that the central transcriptional activator of molecular rhythms, CLOCK, may be particularly important. However, the exact role of this gene in the development of this disorder remains unclear. Here we show that mice carrying a mutation in the Clock gene display an overall behavioral profile that is strikingly similar to human mania, including hyperactivity, decreased sleep, lowered depression-like behavior, lower anxiety, and an increase in the reward value for cocaine, sucrose, and medial forebrain bundle stimulation. Chronic administration of the mood stabilizer lithium returns many of these behavioral responses to wild-type levels. In addition, the Clock mutant mice have an increase in dopaminergic activity in the ventral tegmental area, and their behavioral abnormalities are rescued by expressing a functional CLOCK protein via viral-mediated gene transfer specifically in the ventral tegmental area. These findings establish the Clock mutant mice as a previously unrecognized model of human mania and reveal an important role for CLOCK in the dopaminergic system in regulating behavior and mood.


Asunto(s)
Trastorno Bipolar/genética , Ritmo Circadiano/genética , Transactivadores/genética , Análisis de Varianza , Animales , Síntomas Conductuales/genética , Trastorno Bipolar/tratamiento farmacológico , Trastorno Bipolar/patología , Trastorno Bipolar/terapia , Proteínas CLOCK , Estimulación Eléctrica , Regulación de la Expresión Génica/genética , Técnicas de Transferencia de Gen , Terapia Genética/métodos , Glucógeno Sintasa Quinasa 3/genética , Glucógeno Sintasa Quinasa 3 beta , Inmunohistoquímica , Litio/farmacología , Litio/uso terapéutico , Compuestos de Litio/farmacología , Compuestos de Litio/uso terapéutico , Locomoción/efectos de los fármacos , Ratones , Mutagénesis , Mutación/genética , Transactivadores/uso terapéutico , Área Tegmental Ventral/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA